GH logo

GH Guardant Health, Inc.

NASDAQ Global Select · Medical - Diagnostics & Research · Healthcare

$145.83
+0.24 (+0.16%)

Guardant Health, Inc., established in Redwood City, California, in 2011, is a precision oncology company that delivers a range of diagnostic blood tests, comprehensive data sets, and advanced analytical solutions both within the United States and internationally. For patients with advanced-stage cancer, the company's core offerings include several liquid biopsy-based tests such as Guardant360 (ava…

Market Cap: $19.73Bguardanthealth.com

Price

No data yet.

Social Signal Score

56
5d
56
3 mentions
—
30d
55
10 mentions
—
60d
58
15 mentions
—
90d
56
23 mentions
—
rss: 9 · 4chan: 1 · news: 11 · marketaux: 2

Analyst Ratings

31 analysts
Buyconsensus
Strong Buy 0Buy 30Hold 0Sell 1Strong Sell 0
Avg price target$203.4+39.5%
Low $180Median $200High $225
Current Consensus

Revenue

$360.98M+3759.04%
$9.35M$126.56M$243.77M$360.98M
Mar 2017Sep 2026

Analyst Estimates

FY2025
$-3.08
$-3.19–$-3.01
12 analysts
FY2026
$-3.41
$-3.56–$-3.29
13 analysts
FY2027
$-2.21
$-8.26–$3.69
13 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Helmy Eltoukhy
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
2,498
Beta
1.66
Country
US
Piotroski score
3 / 9 (Weak)
Altman Z-score
3.44
guardanthealth.com